Nanexa AB: Difference between revisions
>Paris Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Nanexa AB (publ) operates as a nanotechnology drug delivery company. It operates PharmaShell, a nanobased drug delivery platform that is an atomic layer deposition. The company also develops NEX-18, which drives the development of a PharmaShell that targets myelodysplastic Syndrome and Acute Myeloid Leukemia. Nanexa AB (publ) was founded in 2007 and is based in Uppsala, Sweden. == References and notes == Category:Thesis..." |
(No difference)
|
Latest revision as of 05:59, 16 August 2022
Summary[1] edit edit source
Nanexa AB (publ) operates as a nanotechnology drug delivery company. It operates PharmaShell, a nanobased drug delivery platform that is an atomic layer deposition. The company also develops NEX-18, which drives the development of a PharmaShell that targets myelodysplastic Syndrome and Acute Myeloid Leukemia. Nanexa AB (publ) was founded in 2007 and is based in Uppsala, Sweden.
References and notes edit edit source
- ↑ Source: Yahoo Finance.